Collaborate With Us

Let's build the next generation of autoimmune biomarkers.

We are seeking collaborators with lupus cohorts, longitudinal samples, therapeutic programs, and immune / multi-omics datasets.

Discuss a Collaboration Meet the Team

Biomedical researchers and a clinician reviewing longitudinal metabolomic data

Who We Work With

A platform built through collaboration.

MetaboType is advanced through partners across the autoimmune ecosystem.

Pharma

Therapeutic development and clinical-trial biomarkers.

Academic investigators

Cohort studies and longitudinal sample programs.

Clinical networks

Lupus and lupus nephritis patient populations.

Foundations

Disease-area strategy and patient impact.

Patient organizations

Community-informed research priorities.

What We're Seeking

Samples, cohorts and data that unlock longitudinal biology.

The platform's value grows with the breadth of longitudinal data connected to clinical outcomes.

Lupus patient cohortsLongitudinal clinical samplesTherapeutic development programsLupus nephritis studiesClinical trial networksBiobanksImmune & multi-omics datasets

What partners receive

Access to longitudinal metabolomic analysis
Candidate biomarker data
Collaborative study design
Integrated analysis with clinical outcomes
Co-development opportunities

What makes a strong collaboration

Well-characterized patient cohort
Longitudinal samples
Paired clinical outcomes
Therapeutic intervention
Disease-activity data
Kidney / nephritis data where relevant

For People Living With Lupus

Stay informed about patient engagement.

MetaboType is in development and is not yet a clinically validated product. If you live with lupus, your interest helps us understand what matters most. Share your contact below and we'll keep you informed about patient-engagement opportunities.

How we collaborate

• Exploratory metabolomic analysis
• Longitudinal biomarker development
• Clinical-trial endpoint support
• Shared data and publication